$13.36 0.3%
ELAN Stock Price vs. AI Score
Data gathered: November 23

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Elanco Animal Health (ELAN)

Analysis generated March 21, 2024. Powered by Chat GPT.

Elanco Animal Health Incorporated operates as an animal health company. It develops, manufactures, and markets products for companion and food animals. The company offers a range of veterinary pharmaceuticals and vaccines, alongside a suite of products and services to enhance animal health and production. As a prominent player in the animal health industry, Elanco is positioned in a market with high barriers to entry and benefits from the growing global demand for proteins and the increasing trend of pet humanization, where pets are treated as family members. These factors drive continuous demand for their products and services.

Read full AI stock Analysis

Stock Alerts - Elanco Animal Health (ELAN)

company logo Elanco Animal Health | November 12
Employee Rating is down by 2.6% over the last month.
company logo Elanco Animal Health | November 12
Business Outlook among employees is down by 3.1% over the last month.
company logo Elanco Animal Health | November 7
Price is up by 9.4% in the last 24h.
company logo Elanco Animal Health | November 3
News Alert: ELANCO ANIMAL HEALTH has been Sued for Securities Fraud after Stock Plummets 21%; Contact the Firm before December 6 Class Action Deadline (NYSE:ELAN)

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.


Elanco Animal Health
Price $13.36
Target Price Sign up
Volume 3,630,000
Market Cap $6.62B
Year Range $11.85 - $18.45
Dividend Yield 0%
PE Ratio 32.68
Analyst Rating 71% buy
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '241.67B965M705M364M750M0.130
Q2 '241.18B1.06B124M-50M164M0.300
Q1 '241.14B1.03B108M32M211M0.340
Q4 '23968M1.04B-1.04B-141M78M0.080
Q3 '23996M956M40M-1.1B-885M0.180

Insider Transactions View All

Harrington Michael J filed to buy 81,094 shares at $14.8.
August 26 '24
Simmons Jeffrey N filed to buy 145,000 shares at $13.
August 13 '24
DOYLE WILLIAM F filed to buy 76,330 shares at $17.
May 23 '24
Harrington Michael J filed to buy 77,594 shares at $16.3.
March 12 '24
DOYLE WILLIAM F filed to buy 61,330 shares at $16.3.
March 12 '24

Congress Trading View All

Politician Filing Date Type Size
Ro Khanna
Oct 8, 24 Buy $1K - $15K
Ro Khanna
Jul 8, 24 Sell $1K - $15K
Rohit Khanna
Democrat
Mar 6, 24 Sell $1K - $15K

What is the Market Cap of Elanco Animal Health?

The Market Cap of Elanco Animal Health is $6.62B.

What is Elanco Animal Health's PE Ratio?

As of today, Elanco Animal Health's PE (Price to Earnings) ratio is 32.68.

What is the current stock price of Elanco Animal Health?

Currently, the price of one share of Elanco Animal Health stock is $13.36.

How can I analyze the ELAN stock price chart for investment decisions?

The ELAN stock price chart above provides a comprehensive visual representation of Elanco Animal Health's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Elanco Animal Health shares. Our platform offers an up-to-date ELAN stock price chart, along with technical data analysis and alternative data insights.

Does ELAN offer dividends to its shareholders?

As of our latest update, Elanco Animal Health (ELAN) does not offer dividends to its shareholders. Investors interested in Elanco Animal Health should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Elanco Animal Health?

Some of the similar stocks of Elanco Animal Health are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.